Afuco™ Anti-Human FCRL5 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-FCRL5 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that specifically bind the extracellular domain of IRTA2 are used to treat B cell malignancies that express IRTA2, such as hairy cell leukemia and non-Hodgkin's lymphoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-261CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | FCRL5 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |